Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. AIDS (London, England) [AIDS] Journal article | | Title | Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. | | Author(s) | Thuret I, Chaix ML, Tamalet C, Reliquet V, Firtion G, Tricoire J, Rabaud C, Frange P, Aumaître H, Blanche S | | Institution | Service d'Hématologie Pédiatrique, CHU Timone, Marseille, France. | | Source | AIDS 2009 Nov 13; 23(17):2364-6. | | Abstract | Twelve heavily pretreated, perinatally infected adolescents in virological failure were treated with a combination of raltegravir, r-darunavir and etravirine, as part of an expanded access program in France. After a 12-month median follow-up, viral load was <400 copies/ml in 11 (<50 in six). No grade > 2 side effects were recorded. Additional data and marketing authorizations are awaited, but preliminary results in adolescents with extensive multidrug resistant virus are encouraging. | | Language | eng | | Pub Type(s) | Journal Article
Research Support, Non-U.S. Gov't
| | PubMed ID | 19823069 |
|
|
| |
Advertise on this site.
| | |
|
